Basic Information
| RNALocate ID: | RLID:11001373 |
| RNA Symbol: | hsa-miR-10a-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-10a-5p |
| RNA ID: | miRBase:MIMAT0000253 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001598 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001599 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001600 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001601 | Nucleus | Colon adenocarcinoma cells | 20864815 |
| RLID:11001370 | Exosome | Cell lines (MCF10A|MCF-7|MDA-MB-231) | 25446899 |
| RLID:11001371 | Exosome | Renal cancer cells | 21670082 |
| RLID:11001372 | Exosome | Brain tissue | 23382797 |
| RLID:11001374 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11001375 | Exosome | Urine | 25135963 |
| RLID:11001376 | Exosome | Cerebrospinal fluid | 25420022 |
| RLID:11001377 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11001378 | Microvesicle | Plasma | 23077538 |
| RLID:11001379 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11001380 | Microvesicle | Hepatoma cells | 23771658 |
| RLID:11001381 | Microvesicle | Cerebrospinal fluid | 24797360 |
| RLID-D:11000046 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000315 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-10a-5p | Diffuse large b cell lymphoma | MNDR-E-MI-04022 |
| MNDR | hsa-miR-10a-5p | Oral squamous cell carcinoma | MNDR-E-MI-04023 |
| MNDR | hsa-miR-10a-5p | Medulloblastoma | MNDR-E-MI-04024 |
| MNDR | hsa-miR-10a-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-04025 |
| MNDR | hsa-miR-10a-5p | Lymphoma | MNDR-E-MI-04026 |
| MNDR | hsa-miR-10a-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-04027 |
| MNDR | hsa-miR-10a-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-04028 |
| MNDR | hsa-miR-10a-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-04029 |
| MNDR | hsa-miR-10a-5p | Niemann-pick disease type c | MNDR-E-MI-04030 |
| MNDR | hsa-miR-10a-5p | Dermatomyositis | MNDR-E-MI-04031 |
| MNDR | hsa-miR-10a-5p | Prostate cancer | MNDR-E-MI-04032 |
| MNDR | hsa-miR-10a-5p | Gastric cancer | MNDR-E-MI-04033 |
| MNDR | hsa-miR-10a-5p | Alzheimer disease | MNDR-E-MI-04034 |
| MNDR | hsa-miR-10a-5p | Intracranial aneurysm | MNDR-E-MI-04035 |
| MNDR | hsa-miR-10a-5p | Urinary bladder cancer | MNDR-E-MI-04036 |
| MNDR | hsa-miR-10a-5p | Dysautonomia familial | MNDR-E-MI-04037 |
| MNDR | hsa-miR-10a-5p | Polycystic ovary syndrome | MNDR-E-MI-04038 |
| MNDR | hsa-miR-10a-5p | Leukemia | MNDR-E-MI-04039 |
| MNDR | hsa-miR-10a-5p | Ataxia telangiectasia | MNDR-E-MI-04040 |
| MNDR | hsa-miR-10a-5p | Friedreich ataxia | MNDR-E-MI-04041 |
| MNDR | hsa-miR-10a-5p | Cardiovascular disease | MNDR-E-MI-04042 |
| MNDR | hsa-miR-10a-5p | Uterine fibroid | MNDR-E-MI-04043 |
| MNDR | hsa-miR-10a-5p | Lung cancer | MNDR-E-MI-04044 |
| MNDR | hsa-miR-10a-5p | Parkinson disease | MNDR-E-MI-04045 |
| MNDR | hsa-miR-10a-5p | Niemann-pick disease | MNDR-E-MI-04046 |
| MNDR | hsa-miR-10a-5p | Basal-like breast cancer | MNDR-E-MI-04047 |
| MNDR | hsa-miR-10a-5p | Thyroid cancer | MNDR-E-MI-04048 |
| MNDR | hsa-miR-10a-5p | Pancreatic cancer | MNDR-E-MI-04049 |
| MNDR | hsa-miR-10a-5p | Melanoma | MNDR-E-MI-04050 |
| MNDR | hsa-miR-10a-5p | Rectum adenocarcinoma | MNDR-E-MI-04051 |
| MNDR | hsa-miR-10a-5p | Nephroblastoma | MNDR-E-MI-04052 |
| MNDR | hsa-miR-10a-5p | Colon cancer | MNDR-E-MI-04053 |
| MNDR | hsa-miR-10a-5p | Colon adenocarcinoma | MNDR-E-MI-04054 |
| MNDR | hsa-miR-10a-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-04055 |
| MNDR | hsa-miR-10a-5p | Familial ovarian cancer | MNDR-E-MI-04056 |
| MNDR | hsa-miR-10a-5p | Prostate adenocarcinoma | MNDR-E-MI-04057 |
| MNDR | hsa-miR-10a-5p | Carcinoma ductal breast | MNDR-E-MI-04058 |
| MNDR | hsa-miR-10a-5p | Glioblastoma | MNDR-E-MI-04059 |
| MNDR | hsa-miR-10a-5p | Glioma | MNDR-E-MI-04060 |
| MNDR | hsa-miR-10a-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-04061 |
| MNDR | hsa-miR-10a-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-04062 |
| MNDR | hsa-miR-10a-5p | Osteosarcoma | MNDR-E-MI-04063 |
| MNDR | hsa-miR-10a-5p | Liposarcoma | MNDR-E-MI-04064 |
| MNDR | hsa-miR-10a-5p | Coronary artery disease | MNDR-E-MI-04065 |
| MNDR | hsa-miR-10a-5p | Breast carcinoma | MNDR-E-MI-04066 |
| MNDR | hsa-miR-10a-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-04067 |
| MNDR | hsa-miR-10a-5p | Liver cancer | MNDR-E-MI-04068 |
| MNDR | hsa-miR-10a-5p | Uterine cancer | MNDR-E-MI-04069 |
| MNDR | hsa-miR-10a-5p | Cervical adenocarcinoma | MNDR-E-MI-04070 |
| MNDR | hsa-miR-10a-5p | Lung squamous cell carcinoma | MNDR-E-MI-04071 |
| MNDR | hsa-miR-10a-5p | Adrenocortical carcinoma | MNDR-E-MI-04072 |
| MNDR | hsa-miR-10a-5p | Thyroid carcinoma | MNDR-E-MI-04073 |
| MNDR | hsa-miR-10a-5p | Tuberculosis | MNDR-E-MI-04074 |
| MNDR | hsa-miR-10a-5p | Pancreatic adenocarcinoma | MNDR-E-MI-04075 |
| MNDR | hsa-miR-10a-5p | Cervical cancer | MNDR-E-MI-04076 |
| MNDR | hsa-miR-10a-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-04077 |
| MNDR | hsa-miR-10a-5p | Carcinoma renal cell | MNDR-E-MI-04078 |
| MNDR | hsa-miR-10a-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-04079 |
| MNDR | hsa-miR-10a-5p | Clear cell renal cell carcinoma | MNDR-E-MI-04080 |
| MNDR | hsa-miR-10a-5p | Cholangiocarcinoma | MNDR-E-MI-04081 |
| MNDR | hsa-miR-10a-5p | Esophageal cancer | MNDR-E-MI-04082 |
| MNDR | hsa-miR-10a-5p | Oncocytoma | MNDR-E-MI-04083 |
| MNDR | hsa-miR-10a-5p | Breast invasive carcinoma | MNDR-E-MI-04084 |
| MNDR | hsa-miR-10a-5p | Hepatocellular carcinoma | MNDR-E-MI-04085 |
| MNDR | hsa-miR-10a-5p | Familiar ovarian carcinoma | MNDR-E-MI-04086 |
| MNDR | hsa-miR-10a-5p | B-cell lymphoma | MNDR-E-MI-04087 |
| MNDR | hsa-miR-10a-5p | Rheumatoid arthritis | MNDR-E-MI-04088 |
| MNDR | hsa-miR-10a-5p | Neuroblastoma | MNDR-E-MI-04089 |
| MNDR | hsa-miR-10a-5p | Chronic fatigue syndrome | MNDR-E-MI-04090 |
| MNDR | hsa-miR-10a-5p | Chronic myeloid leukemia | MNDR-E-MI-04091 |
| MNDR | hsa-miR-10a-5p | Hodgkin lymphoma | MNDR-E-MI-04092 |
| MNDR | hsa-miR-10a-5p | Neuromyelitis optica | MNDR-E-MI-04093 |
| MNDR | hsa-miR-10a-5p | Psoriasis | MNDR-E-MI-04094 |
| MNDR | hsa-miR-10a-5p | Skin cutaneous melanoma | MNDR-E-MI-04095 |
| MNDR | hsa-miR-10a-5p | Skin melanoma | MNDR-E-MI-04096 |
| MNDR | hsa-miR-10a-5p | Acute myelocytic leukemia | MNDR-E-MI-04097 |
| MNDR | hsa-miR-10a-5p | Colorectal cancer | MNDR-E-MI-04098 |
| MNDR | hsa-miR-10a-5p | Nasopharynx carcinoma | MNDR-E-MI-04099 |
| MNDR | hsa-miR-10a-5p | Multiple myeloma | MNDR-E-MI-04100 |
| MNDR | hsa-miR-10a-5p | Abortion spontaneous | MNDR-E-MI-04101 |
| MNDR | hsa-miR-10a-5p | Uterine cervical neoplasms | MNDR-E-MI-04102 |
| MNDR | hsa-miR-10a-5p | Ependymoma | MNDR-E-MI-04103 |
| MNDR | hsa-miR-10a-5p | Cardiomegaly | MNDR-E-MI-04104 |
| MNDR | hsa-miR-10a-5p | Nasopharyngeal cancer | MNDR-E-MI-04105 |
| MNDR | hsa-miR-10a-5p | Prostatic neoplasms | MNDR-E-MI-04106 |
| MNDR | hsa-miR-10a-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-04107 |
| MNDR | hsa-miR-10a-5p | Gait ataxia | MNDR-E-MI-04108 |
| MNDR | hsa-miR-10a-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-04109 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCB1 | Homo sapiens | RR00022771 |
TOP